title: [Efficacy of hypofractionated radiotherapy combined with docetaxel for treatment of bone metastasis of lung cancer].
abstract: OBJECTIVE
  To evaluate the efficacy of hypofractionated radiotherapy combined with docetaxel for treatment of bone metastasis of lung cancer and explore the factors related to the prognosis.
  
  
  METHODS
  Seventy-two patients with bone metastasis of lung cancer were divided into group A with hypofractionated radiotherapy at 3.0 Gy /fraction (once a day, 5 days per week for 30 Gy) and weekly docetaxel treatment at 60 mg for 2 weeks, and group B with radiotherapy alone at 2.0 Gy/fraction (once a day, 5 days per week for 40 Gy).
  
  
  RESULTS
  The total effective rate was 93.1% (67/72) in these patients, with a non-response rate of 6.9% (5/72). The total effective rate was 97.2% (35/36) in group A and 88.9% (32/36) in group B. After the radiotherapy, the analgesic effect showed no significant difference between the two groups, but the onset of the effect was faster in group B than in group A.
  
  
  CONCLUSIONS
  Local radiotherapy provides effective pain relief in patients with bone metastasis of lung cancer. High-dose fractionated irradiation can rapidly achieve the analgesic effect.
authors.affiliation: Department of Radiation Oncology, Qingyuan People's Hospital, Fifth Affiliated Hospital of Medical College of Jinan University, Qingyuang 511500, China. fengzhengfu@yahoo.com.cn
authors.forename: Zheng-Fu
authors.initials: ZF
authors.lastname: Feng
authors.forename: Xin
authors.initials: X
authors.lastname: Liu
authors.forename: Zhuo-Mei
authors.initials: ZM
authors.lastname: Liu
authors.forename: Hui-Sheng
authors.initials: HS
authors.lastname: Song
authors.forename: Rui-Ming
authors.initials: RM
authors.lastname: Tang
mesh_terms: D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy* / Q000556:secondary; D003131:Combined Modality Therapy; D000077143:Docetaxel; D019583:Dose Fractionation, Radiation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D043823:Taxoids / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D043823:Taxoids; D000077143:Docetaxel